Helen Torley - PRESIDENT AND CEO, Director at Halozyme Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: PRESIDENT AND CEO, Director
Stock Symbol: HALO on Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
All Insider Reports: All Insider Reports

Helen Torley - trading volume in the past year for Halozyme Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-360K	100%	$64.76	-$23.3M
Net	-360K	-100%		-$23.3M

Holdings reported by Helen Torley for Halozyme Therapeutics, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	734K	$52.6M	$71.67	Nov 12, 2025	Direct
Restricted Stock Units	67.3K	$3.92M	$58.29	Feb 23, 2025	Direct	Common Stock
Performance Stock Unit	23.3K	$1.31M	$56.41	Feb 12, 2025	Direct	Common Stock
Option to Purchase Common Stock	16.6K	$134K	$8.11	Nov 12, 2025	Direct	Common Stock
Performance Stock Units	0	$0	$56.41	Feb 16, 2025	Direct	Common Stock

Transactions reported by Helen Torley for Halozyme Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.